Aspirin as secondary prevention in colorectal cancer liver metastasis (ASAC trial): study protocol for a multicentre randomized placebo-controlled trial.

Sheraz YaqubBjørn Atle BjørnbethJon-Helge AngelsenClaus Wilki FristrupJon Erik GrønbechOskar HemmingssonBengt IsakssonIngebjørg Soterud JuelPeter Nørgaard LarsenGert LindellFrank Viborg MortensenKim Erlend MortensenMagnus RizellPer SandströmOddvar Mathias SandvikErnesto SparrelidHelena TaflinKjetil Taskénnull null

Published in: Trials (2021)

ClinicalTrials.gov NCT03326791 . Registered on 31 October 2017.

Keyphrases

double blind
phase iii
placebo controlled
phase ii
study protocol
clinical trial
low dose
open label
cardiovascular events
antiplatelet therapy
acute coronary syndrome
type diabetes
coronary artery disease
cardiovascular disease